Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2400089108Phase 4Not yet recruiting
Phase 4, randomised trial in pituitary neoplasm comparing Ciprofol arm with Propofol arm (2 arms). Primary endpoint: Awakening quality during the awakening period. Planned start Sep 2024; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2400089108.